相关实验视频
Updated: May 24, 2025

07:58
Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
7.3K
身体组成和血液恶性瘤之间的因果关系:一个多变量孟德尔随机化分析
Shan Liu1, Yaobin Lin2, Zhihong Wang3,4
1Department of Hematology-Oncology, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Children's Hospital, Fuzhou, Fujian, China.
Cancer causes & control : CCC
|March 4, 2025
概括
身体成分会影响癌症的风险. 特定的身体脂肪和体重测量与白血病和淋巴瘤风险增加有关,而身高和腰比是淋巴瘤和多发性骨髓瘤的独立风险因素.
科学领域:
- 遗传学和流行病学
- 癌症研究 癌症研究
- 代谢健康 代谢健康
背景情况:
- 人体构成与血液恶性瘤之间的联系尚不清楚.
- 这项研究调查了人体组成和血液癌症之间的遗传关联.
研究的目的:
- 通过使用孟德尔随机化 (MR) 来评估身体组成和血液恶性瘤之间的因果关系.
主要方法:
- 利用了来自约50万名参与者 (40-69岁) 的英国生物库数据.
- 采用多变量MR分析和反变量加权 (IVW) 方法.
- 进行敏感性分析以评估异质性和性.
主要成果:
- 患白血病的风险增加与手臂无脂肪质量,干预测质量,全身无脂肪质量和全身水质量有关.
- 淋巴瘤的风险增加与手臂,腿,干和全身的各种脂肪和无脂肪质量测量有关.
- 身高是淋巴瘤的一个独立风险因素 (OR=1.004,p=0.040).
- 腰部至部的比率是多发性骨髓瘤的危险因素 (OR=1.003,p=0.004).
结论:
- 身高和腰比被确定为特定血液性恶性瘤的独立风险因素.
- 研究结果支持人体成分与患血液癌症的风险之间存在因果关系.
相关概念视频
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Mechanistic Models: Compartment Models in Individual and Population Analysis
23
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
23
Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319
Comparing the Survival Analysis of Two or More Groups
117
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
117

